FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
SAN FRANCISCO, April 06, 2016 -- Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, today announced that company management is scheduled to present at the 15th Annual Needham Healthcare Conference on Wednesday, April 13, 2016, at 11:20 a.m. ET in New York City.
A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Invuity®
Invuity, Inc. is a medical technology company focused on developing and marketing advanced photonics devices to improve the ability of surgeons to illuminate and visualize the surgical cavity during minimally invasive and minimal access open surgery. The company's patented Intelligent Photonics™ technology enables enhanced surgical precision, efficiency and safety by providing superior visualization. Clinical applications include breast and thyroid oncology, plastic reconstructive, spine, orthopedic, cardiothoracic and general surgery among others. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT: Company Contact: Jim Mackaness, CFO Invuity, Inc. 415-655-2100 Investors: Matt Clawson Pure Communications 949-370-8500 [email protected]
